Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
 Back to Profile

Krishna Nalleballe

Concepts (163)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Stroke
14
2022
515
2.450
 Why?
Thrombolytic Therapy
4
2022
112
1.210
 Why?
Pneumonia, Viral
6
2020
178
1.210
 Why?
Fibrinolytic Agents
4
2022
131
1.200
 Why?
Coronavirus Infections
6
2020
189
1.190
 Why?
Tissue Plasminogen Activator
3
2020
109
1.170
 Why?
Pandemics
8
2020
587
0.790
 Why?
Endovascular Procedures
2
2022
179
0.780
 Why?
Cavernous Sinus
1
2022
15
0.750
 Why?
Carotid-Cavernous Sinus Fistula
1
2022
12
0.750
 Why?
Embolization, Therapeutic
1
2022
88
0.690
 Why?
Conflict of Interest
2
2020
26
0.690
 Why?
Iodine Compounds
1
2020
7
0.670
 Why?
Brain Edema
1
2020
36
0.650
 Why?
Contrast Media
1
2020
175
0.610
 Why?
Brain Ischemia
4
2022
162
0.610
 Why?
Mucopolysaccharidosis II
1
2018
1
0.600
 Why?
Cardiology
1
2020
101
0.590
 Why?
Medicare
1
2020
274
0.580
 Why?
Coronary Angiography
1
2020
388
0.580
 Why?
Physicians
1
2020
241
0.530
 Why?
Hospitalization
6
2022
749
0.450
 Why?
Humans
31
2025
52593
0.410
 Why?
Databases, Factual
3
2020
715
0.400
 Why?
Telemedicine
1
2019
493
0.390
 Why?
Aged
12
2025
10191
0.380
 Why?
Headache
2
2022
76
0.350
 Why?
Time Factors
4
2020
3000
0.330
 Why?
Autoimmune Diseases
2
2020
87
0.320
 Why?
Ischemic Attack, Transient
2
2020
59
0.310
 Why?
United States
7
2025
5227
0.310
 Why?
Immunosuppressive Agents
2
2020
250
0.300
 Why?
Female
18
2025
28262
0.290
 Why?
Male
16
2025
26863
0.280
 Why?
Middle Aged
13
2025
13096
0.270
 Why?
Cerebral Hemorrhage
2
2025
100
0.270
 Why?
Arkansas
4
2019
2029
0.250
 Why?
Receptors, Granulocyte-Macrophage Colony-Stimulating Factor
1
2025
2
0.240
 Why?
Frontotemporal Dementia
1
2025
4
0.240
 Why?
Emergency Service, Hospital
2
2020
524
0.240
 Why?
Secondary Prevention
1
2025
85
0.230
 Why?
Gastrointestinal Hemorrhage
1
2025
90
0.230
 Why?
Tomography, X-Ray Computed
2
2020
1162
0.210
 Why?
Triage
2
2021
66
0.210
 Why?
Platelet Aggregation Inhibitors
1
2025
213
0.210
 Why?
Retrospective Studies
6
2025
6671
0.210
 Why?
Drug Industry
2
2020
40
0.200
 Why?
Thrombectomy
2
2020
73
0.200
 Why?
Neuroimaging
2
2020
94
0.200
 Why?
Atrial Fibrillation
1
2025
201
0.200
 Why?
Anticoagulants
1
2025
279
0.190
 Why?
Critical Care
2
2021
222
0.190
 Why?
Aged, 80 and over
4
2025
3420
0.180
 Why?
Sinus Thrombosis, Intracranial
1
2021
16
0.180
 Why?
Myasthenia Gravis
1
2021
19
0.170
 Why?
Hospitalists
1
2020
11
0.170
 Why?
Intracranial Thrombosis
1
2020
16
0.170
 Why?
Ageusia
1
2020
6
0.170
 Why?
Olfaction Disorders
1
2020
7
0.170
 Why?
Neuromuscular Diseases
1
2020
31
0.170
 Why?
Myocardial Infarction
2
2025
448
0.170
 Why?
Health Services Misuse
1
2020
13
0.170
 Why?
Osmolar Concentration
1
2020
62
0.170
 Why?
Lymphoma, Non-Hodgkin
1
2020
58
0.170
 Why?
Health Care Sector
1
2020
15
0.160
 Why?
Neurologic Examination
1
2020
73
0.160
 Why?
Infarction, Middle Cerebral Artery
1
2020
40
0.160
 Why?
Mood Disorders
1
2020
59
0.160
 Why?
Multiple Sclerosis
1
2020
72
0.160
 Why?
Time-to-Treatment
1
2020
78
0.160
 Why?
Venous Thrombosis
1
2020
90
0.160
 Why?
Patient Transfer
1
2020
99
0.160
 Why?
Brain Diseases
1
2020
77
0.160
 Why?
Young Adult
2
2020
4337
0.160
 Why?
Subarachnoid Hemorrhage
1
2020
60
0.160
 Why?
Drug-Eluting Stents
1
2020
102
0.160
 Why?
Suicidal Ideation
1
2020
109
0.160
 Why?
Recombinant Fusion Proteins
1
2010
175
0.160
 Why?
Fabry Disease
1
2019
9
0.160
 Why?
Enzyme Replacement Therapy
1
2019
17
0.160
 Why?
Hospitals
1
2020
184
0.150
 Why?
Nervous System Diseases
1
2020
94
0.150
 Why?
Tomography Scanners, X-Ray Computed
1
2018
11
0.150
 Why?
Angiogenesis Inhibitors
1
2010
184
0.150
 Why?
Fluorocarbons
1
2019
61
0.150
 Why?
Angiography, Digital Subtraction
1
2018
27
0.150
 Why?
Neuroprotective Agents
1
2019
101
0.150
 Why?
Seizures
1
2020
209
0.140
 Why?
Pain
1
2020
362
0.140
 Why?
Anxiety
1
2020
301
0.140
 Why?
Pulmonary Disease, Chronic Obstructive
1
2019
146
0.140
 Why?
Meningitis
1
2016
25
0.130
 Why?
Referral and Consultation
1
2019
292
0.130
 Why?
Diagnosis, Differential
1
2020
1048
0.130
 Why?
Adult
6
2025
14170
0.130
 Why?
Antibodies, Monoclonal
1
2010
478
0.120
 Why?
Percutaneous Coronary Intervention
1
2020
328
0.120
 Why?
Ovarian Neoplasms
1
2010
460
0.120
 Why?
Plasma Cells
1
2016
239
0.120
 Why?
Magnetic Resonance Imaging
2
2020
1545
0.110
 Why?
RNA-Directed DNA Polymerase
1
2002
5
0.100
 Why?
Oligodeoxyribonucleotides
1
2002
30
0.100
 Why?
DNA, Complementary
1
2002
131
0.100
 Why?
Adolescent
2
2020
6737
0.090
 Why?
Antineoplastic Agents
1
2010
1221
0.090
 Why?
Mycobacterium tuberculosis
1
2002
292
0.080
 Why?
Treatment Outcome
4
2022
5486
0.080
 Why?
Risk Factors
3
2025
3952
0.080
 Why?
Intubation, Intratracheal
2
2021
118
0.080
 Why?
Risk Assessment
2
2025
1350
0.070
 Why?
Cross-Sectional Studies
2
2025
1686
0.070
 Why?
Cohort Studies
2
2022
1553
0.070
 Why?
Prevalence
2
2020
1017
0.070
 Why?
Receptor, Macrophage Colony-Stimulating Factor
1
2025
5
0.060
 Why?
Mexico
1
2025
37
0.060
 Why?
Propensity Score
1
2025
158
0.060
 Why?
Drug Therapy, Combination
1
2025
400
0.050
 Why?
Intracranial Hemorrhages
1
2022
41
0.050
 Why?
Multiple Myeloma
1
2016
3050
0.050
 Why?
Cranial Sinuses
1
2021
8
0.050
 Why?
Industry
1
2020
16
0.040
 Why?
Arthritis, Psoriatic
1
2020
9
0.040
 Why?
Spondylitis, Ankylosing
1
2020
10
0.040
 Why?
Cranial Nerves
1
2020
14
0.040
 Why?
Disease Susceptibility
1
2021
96
0.040
 Why?
Endocrine System Diseases
1
2010
9
0.040
 Why?
Receptors, Vascular Endothelial Growth Factor
1
2010
24
0.040
 Why?
Mortality
1
2020
105
0.040
 Why?
Colitis, Ulcerative
1
2020
67
0.040
 Why?
Arthritis, Rheumatoid
1
2020
118
0.040
 Why?
Maximum Tolerated Dose
1
2019
39
0.040
 Why?
Disease Outbreaks
1
2020
123
0.040
 Why?
Tertiary Care Centers
1
2019
83
0.040
 Why?
Administration, Oral
1
2020
455
0.040
 Why?
alpha-Galactosidase
1
2019
9
0.040
 Why?
Administration, Intravenous
1
2019
74
0.040
 Why?
Mutation
1
2025
1344
0.040
 Why?
Registries
1
2022
629
0.040
 Why?
Crohn Disease
1
2020
117
0.040
 Why?
Disability Evaluation
1
2019
92
0.040
 Why?
Hemorrhage
1
2020
224
0.040
 Why?
Skin Diseases
1
2010
115
0.040
 Why?
Gastrointestinal Diseases
1
2010
125
0.040
 Why?
Drug Administration Schedule
1
2019
376
0.040
 Why?
Recovery of Function
1
2019
202
0.040
 Why?
Electronic Health Records
1
2021
269
0.040
 Why?
Antibodies, Monoclonal, Humanized
1
2010
237
0.040
 Why?
Comorbidity
1
2019
631
0.030
 Why?
Double-Blind Method
1
2019
718
0.030
 Why?
Patient Readmission
1
2019
246
0.030
 Why?
Prognosis
1
2022
2118
0.030
 Why?
Fatal Outcome
1
2016
196
0.030
 Why?
Follow-Up Studies
1
2020
2291
0.030
 Why?
Prospective Studies
1
2020
2457
0.030
 Why?
Cardiovascular Diseases
1
2010
495
0.030
 Why?
DNA Primers
1
2002
206
0.020
 Why?
Infant
1
2020
3720
0.020
 Why?
Child, Preschool
1
2020
4062
0.020
 Why?
Oligonucleotide Array Sequence Analysis
1
2002
412
0.020
 Why?
Transcription, Genetic
1
2002
380
0.020
 Why?
Gene Expression Regulation, Bacterial
1
2002
187
0.020
 Why?
RNA, Messenger
1
2002
1139
0.020
 Why?
Child
1
2020
7229
0.020
 Why?
Nalleballe's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (163) concept(s)
_
Co-Authors Expand Description
See all (20) people
_
Similar People Expand Description
See all (35) people
_
Same Department Expand Description
Search Department